Huang's latest comments helped spark a gain in Nvidia stock, but these three catalysts could power the stock even higher in the fourth quarter.

The voluntary carbon market (VCM) is evolving and capturing the interest of corporate actors, Nasdaq found in its newly released 2024 Global Net Zero Pulse report .

At 93 years old, Warren Buffett is the definition of a self-made billionaire. He bought his first stocks for $38 each at age 11 and sold them for a total profit of $12. By age 14, he had saved enough ...

Micron makes DRAM memory chips and NAND flash memory storage chips. Things changed when Micron reported a 93.3% YoY revenue surge in its fiscal fourth quarter of 2024 earnings release, beating ...

When Americans switch jobs, they often see a boost in earnings — but if they’re not careful, a common 401(k) mistake can be a major setback for their retirement savings. A 401(k) allows you to ...

For fiscal 2024, analysts expect AT&T to report an EPS of $2.22, down 7.9% from $2.41 in fiscal 2023. However, fiscal 2025 EPS is projected to grow 5.4% annually to $2.34.

Cisco's robust business model and solid financial performance make it a compelling investment for those seeking capital appreciation and a consistent income stream. The company recently delivered ...

There is no company that's benefited more from the artificial intelligence (AI) hype than Nvidia (NASDAQ: NVDA). Demand for the company's graphics processing units (GPU), data center services, and ...

Billionaire investors are generally looking for strong companies with clear catalysts for profitable growth, and that's why Loeb and Halvorsen have large bets on Amazon. Analysts expect Amazon's ...

Lately, all eyes have been on the 2025 Social Security cost-of-living adjustment (COLA) and the effect it will have on benefits next year. Checks will go up beginning in January, though we won't ...

Real time quote data is not available at this time.

Innate Pharma (Nasdaq: IPHA), a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness ...